“The state drug controllers (SDCs) and meals and medicines directors (FDAs) of all of the states and union territories have been requested to have a detailed vigilance available in the market to verify the sale of masks and sanitizers on the charges greater than the MRP,” the drug pricing authority stated in a tweet.
NPPA had earlier written to chief secretaries of states, principal secretaries (well being) and state drug controllers, urging them to carefully monitor the manufacturing and availability of APIs and formulations to forestall black advertising and marketing and hoarding of their states or UTs.
NPPA Chairman Shubhra Singh on Thursday met representatives of pharmaceutical industry associations on the difficulty of availability of vital energetic pharmaceutical substances (APIs).
“It’s assured that enough inventory of vital APIs and formulations is on the market to satisfy the necessities of the scenario arising out of COVID-19,” NPPA had stated in a tweet.
NPPA is an impartial regulator for pricing of medicine and to make sure availability and accessibility of medicines at inexpensive costs.